Millions of Americans miss out on HIV prevention medication due to access barriers

kffhealthnews.org

Millions of Americans who could benefit from HIV prevention medication are not receiving it due to various barriers. Only about a quarter of the estimated over 2 million Americans eligible for PrEP are currently using it. This underutilization is attributed to billing errors, lack of awareness, and persistent stigma. Experts suggest patients can overcome these hurdles by seeking doctors knowledgeable about PrEP and navigating potential access issues.


With a significance score of 4.9, this news ranks in the top 1.4% of today's 25468 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers: